Point72 Asset Management
NEUP

Point72 Asset Management’s Neuphoria Therapeutics NEUP Stock Holding History

Point72 Asset Management’s Portfolio NEUP Stock Details NEUP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26,333
Closed -$139K – 2791
2024
Q3 		$139K Hold
26,333
– – ﹤0.01% 1837
2024
Q2 		$242K Hold
26,333
– – ﹤0.01% 1579
2024
Q1 		$325K Sell
26,333
-1,250
-5% -$16.5K ﹤0.01% 1764
2023
Q4 		$490K Sell
27,583
-27,553
-50% -$786K ﹤0.01% 1586
2023
Q3 		$1.79M Buy
55,136
+44,636
+425% +$962K 0.01% 1169
2023
Q2 		$277K Sell
10,500
-167
-2% -$4.63K ﹤0.01% 1373
2023
Q1 		$333K Hold
10,667
– – ﹤0.01% 1340
2022
Q4 		$595K Buy
+10,667
New +$926K ﹤0.01% 1129

Other funds holding NEUP

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return